您的位置：首页 >> 制药产品大全 >> 原料药 >> Ticagrelor
Ticagrelor tablets are indicated to reduce the risk of cardiovascular death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of MI. For at least the first 12 months following ACS, it is superior to clopidogrel.
Ticagrelor tablets also reduce the risk of stent thrombosis in patients who have been stented for treatment of ACS
TicagrelorCAS号：274693-27-5
Ticagrelor分子式： C23H28F2N6O4S
Ticagrelor英文名称： (1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor英文同义词： Ticagrelor; AR-C126532; AZD6140; (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol
Ticagrelor分子量： 522.568
原料药
申请入驻
